Exact Sciences Cor (EXAS)
$148.07 2.30 (1.53%)
18:05 EST EXAS Stock Quote Delayed 30 Minutes
Previous Close -
Market Cap 18.05B
PE Ratio -148.07
Volume (Avg. Vol.) 1.27M
Day's Range 147.01 - 151.19
52-Week Range 35.25 - 152.87
Dividend & Yield N/A (N/A)
EXAS Stock Predictions, Articles, and Exact Sciences Cor News
- From InvestorPlace
- From the Web
Exact Sciences (EXAS) stock was flying high on Tuesday following a flurry of news from the molecular diagnostics company.
Despite the level of uncertainty as we enter 2020, we've found seven stocks that look like the new decade’s showstoppers.
These ten growth stocks saw the highest percentage growth over the last decade, and some remain unknown to investors despite huge increases.
The 13-F filing for Warren Buffett's Berkshire Hathaway is out. Here's what happened in the stock market today.
These drug stocks are among the best to buy now because each is making progress in the fight against cancer. Here's what you should know about each.
Which top stocks are Wall Street analysts the most bullish on? These strong buy stocks deserve a spot on your watch list.
InVitae, Crispr and Myriad are just some of the genomic testing stocks worth a look as DNA becomes a more important part of healthcare.
We explain the surge of MBOT stock and describe the products that could lead to much higher prices for Microbot stock in the future.
These biotech stocks are set for a strong comeback as investors start to walk away from large-cap tech companies. Here's what investors need to know about each company.
Exact Sciences is a rapidly growing biotech firm whose decline looks overdone. Seasonal strength in the second quarter could renew bullish sentiment in EXAS stock.
Exact Sciences (EXAS) drops to a Buy this week based on the latest news, and comparative pricing of its shares.
3 Stocks to Watch on Friday: Advanced Micro Devices, Inc. (AMD), EXACT Sciences Corporation (EXAS) and International Business Machines Corp. (IBM)
Advanced Micro Devices (AMD) said chips have vulnerability, EXACT Sciences (EXAS) launches $500M offering and IBM (IBM) to cut 10,000 jobs.
Profitability analysis is used to measure the company’s ability to manage its revenues effectively and provide stunning returns to its investors.
Navellier RatingsPowered by Portfolio Grader